Find grants

4 grants for “Oligo”

Closing: this week (0) · this month (0) · next 3 months (0)
  1. Federal

    Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

    National Institutes of Health · Department of Health and Human Services · Open

    Deadline
    Due Oct 8, 2027 · 365 days left
    Award
    Amount not specified
    • Available in Tennessee (nationwide program)
    • No match required
    • Past Tennessee awards on file: 106

    The Ultra-Rare Gene-Based Therapy (URGenT) network supports Investigational New Drug (IND)-enabling studies and planning activities for First-in-Human (FIH) clinical testing of gene-based or transcript-directed therapeutics, such as oligonucleotides and...

    Checked today against the source

  2. Federal

    Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

    National Institutes of Health · Department of Health and Human Services · Open

    Deadline
    Due Aug 18, 2027 · 314 days left
    Award
    Amount not specified
    • Available in Tennessee (nationwide program)
    • No match required
    • Past Tennessee awards on file: 693

    The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports...

    Checked today against the source

  3. Federal

    Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

    Food and Drug Administration · Department of Health and Human Services · Opening soon

    Deadline
    Opening date not announced
    Award
    Up to $300K
    • Available in Tennessee (nationwide program)
    • No match required
    • Past Tennessee awards on file: 42

    The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each...

    Checked today against the source

  4. Federal

    RNomics Molecular Standards

    National Institutes of Health · Department of Health and Human Services · Opening soon

    Deadline
    Due about Feb 15, 2027 Estimate, not confirmed by the funder
    Award
    Amount not specified
    • Available in Tennessee (nationwide program)
    • No match required
    • Past Tennessee awards on file: 82

    The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and...

    Checked today against the source

Get these deadlines in your calendar

Add every upcoming deadline from this search to Outlook, Google or Apple Calendar. You'll get reminders 30 and 7 days before each one. A subscribed calendar updates by itself when grants are added or dates change. No account or email needed.

Subscribe (updates automatically) Download once (.ics)

Google Calendar: right-click “Download once” and copy the link address. In Google Calendar choose “Other calendars → From URL”, then paste it. It will keep updating.

Follow new grants for this search

Paste this feed link into a feed reader (Feedly, Inoreader), Outlook's RSS folder, or a Slack or Teams RSS app. New grants that match this search show up there as GrantMe adds them. No account or email needed.

RSS feed for this search This week's new grants